TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BRVE

Braveheart Bio, Inc.

Healthcare · Biotechnology

21.10$ +2.2% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Braveheart Bio, Inc. (BRVE): report dates, earnings surprises, earnings call transcripts and the latest headlines.

Next report –
Last report 09/08/2026
Earnings surprise by quarter (%)
Q2 26 · -904.0 % 26

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 Braveheart Bio, Inc. (BRVE): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?